Natalizumab affects the t-cell receptor repertoire in patients with multiple sclerosis

Neurology

Volumn 81, Issue 16, 2013, Pages 1400-1408

  Warnke, Clemens ^a,b   Mausberg, Anne K ^a   Stettner, Mark ^a   Dehmel, Thomas ^a   Nekrich, Lina ^a   Horste, Gerd Meyer Zu ^a   Hartung, Hans Peter ^a   Fogdell Hahn, Anna ^b   Adams, Ortwin ^a   Kieseier, Bernd C ^a  

^a Department of Orthopedic Surgery   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; NATALIZUMAB; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD; CONTROLLED STUDY; DRUG EFFECT; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSURVEILLANCE; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PLASMA EXCHANGE; RECEPTORS, ANTIGEN, T-CELL; YOUNG ADULT;

EID: 84888261112     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182a84101     Document Type: Article

References (40)

1. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992;356:63-66.
2. Engelhardt B, Ransohoff RM. Capture, crawl, cross: The T cell code to breach the blood-brain barriers. Trends Immunol 2012;33:579-589.
3. Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 2012;12:623-635.
4. Pilar Martin M, Cravens PD, Winger R, et al. Decrease in the numbers of dendritic cells and CD41 T cells in cerebral perivascular spaces due to natalizumab. Arch Neurol 2008;65:1596-1603.
5. Stuve O, Marra CM, Bar-Or A, et al. Altered CD41/CD81 T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol 2006;63: 1383-1387.
6. Stuve O, Marra CM, Jerome KR, et al. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol 2006;59:743-747.
7. Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab- associated progressive multifocal leukoencephalopathy. N Engl J Med 2012;366:1870-1880.
8. Warnke C, Adams O, Hartung HP, et al. Risk stratification of progressive multifocal leukoencephalopathy under natalizumab: recommendations for JC virus serology. Nervenarzt 2011;82:1314-1319.
9. Warnke C, Menge T, Hartung HP, et al. Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided? Arch Neurol 2010;67:923-930.
10. Kotzin BL, Karuturi S, Chou YK, et al. Preferential T-cell receptor beta-chain variable gene use in myelin basic proteinreactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 1991;88:9161-9165.
11. Laplaud DA, Ruiz C, Wiertlewski S, et al. Blood T-cell receptor beta chain transcriptome in multiple sclerosis: characterization of the T cells with altered CDR3 length distribution. Brain 2004;127:981-995.
12. Gran B, Gestri D, Sottini A, et al. Detection of skewed T-cell receptor V-beta gene usage in the peripheral blood of patients with multiple sclerosis. J Neuroimmunol 1998; 85:22-32.
13. Muraro PA, Bonanni L, Mazzanti B, et al. Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS. J Neuroimmunol 2002;127: 149-159.
14. Matsumoto Y, Yoon WK, Jee Y, et al. Complementaritydetermining region 3 spectratyping analysis of the TCR repertoire in multiple sclerosis. J Immunol 2003;170: 4846-4853.
15. Oksenberg JR, Panzara MA, Begovich AB, et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993;362:68-70.
16. Babbe H, Roers A, Waisman A, et al. Clonal expansions of CD8(1) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000;192:393-404.
17. Skulina C, Schmidt S, Dornmair K, et al. Multiple sclerosis: brain-infiltrating CD81 T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci USA 2004;101:2428-2433.
18. Muraro PA, Cassiani-Ingoni R, Chung K, Packer AN, Sospedra M, Martin R. Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis. J Neuroimmunol 2006;171:177-183.
19. Junker A, Ivanidze J, Malotka J, et al. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 2007;130:2789-2799.
20. Mausberg AK, Dorok M, Stettner M, et al. Recovery of the T-cell repertoire in CIDP by IV immunoglobulins. Neurology 2013;80:296-303.
21. Wu CJ, Chillemi A, Alyea EP, et al. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood 2000;95:352-359.
22. Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, Corboy J, Vollmer T. Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab. J Neuropathol Exp Neurol 2012;71:604-617.
23. Tan IL, McArthur JC, Clifford DB, Major EO, Nath A. Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 2011;77:1061-1067.
24. Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 2010;9:438-446.
25. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
26. Joller N, Peters A, Anderson AC, Kuchroo VK. Immune checkpoints in central nervous system autoimmunity. Immunol Rev 2012;248:122-139.
27. Hohlfeld R, Dornmair K. What T-cell receptors can tell us about neurologic disease. Neurology 2012;78:376-377.
28. Lozeron P, Chabas D, Duprey B, Lyon-Caen O, Liblau R. T cell receptor V beta 5 and V beta 17 clonal diversity in cerebrospinal fluid and peripheral blood lymphocytes of multiple sclerosis patients. Mult Scler 1998;4:154-161.
29. Saure C, Warnke C, Zohren F, et al. Natalizumab and impedance of the homing of CD341 hematopoietic progenitors. Arch Neurol 2011;68:1428-1431.
30. von Andrian UH, Engelhardt B. Alpha4 integrins as therapeutic targets in autoimmune disease. N Engl J Med 2003;348:68-72.
31. Cauley LS, Lefrancois L. Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells. Mucosal Immunol 2013;6:14-23.
32. Kadioglu A, De Filippo K, Bangert M, et al. The integrins Mac-1 and alpha4beta1 perform crucial roles in neutrophil and T cell recruitment to lungs during Streptococcus pneumoniae infection. J Immunol 2011;186:5907-5915.
33. Odoardi F, Sie C, Streyl K, et al. T cells become licensed in the lung to enter the central nervous system. Nature 2012;488:675-679.
34. Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011;479:538-541.
35. Schwab N, Hohn KG, Schneider-Hohendorf T, et al. Immunological and clinical consequences of treating a patient with natalizumab. Mult Scler 2012;18:335-344.
36. Rothhammer V, Heink S, Petermann F, et al. Th17 lymphocytes traffic to the central nervous system independently of alpha4 integrin expression during EAE. J Exp Med 2011;208:2465-2476.
37. Clifford DB. Lessons from the clinic: A case of natalizumabassociated PML. Neurology 2011;76:574.
38. Aly L, Yousef S, Schippling S, et al. Central role of JC virus-specific CD41 lymphocytes in progressive multifocal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain 2011;134:2687-2702.
39. Metz I, Radue EW, Oterino A, et al. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol 2012;123:235-245.
40. Yousef S, Planas R, Chakroun K, et al. TCR bias and HLA cross-restriction are strategies of human brain-infiltrating JC virus-specific CD41 T cells during viral infection. J Immunol 2012;189:3618-3630.